KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $80.0 million.

  • Idexx Laboratories' Shares Outstanding (Weighted Average) fell 2.80% to $80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year decrease of 2.80%. This contributed to the annual value of $81.9 million for FY2024, which is 1.45% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Shares Outstanding (Weighted Average) is $80.0 million, which was down 0.52% from $80.4 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Shares Outstanding (Weighted Average) ranged from a high of $85.4 million in Q1 2021 and a low of $80.0 million during Q3 2025.
  • Over the past 3 years, Idexx Laboratories' median Shares Outstanding (Weighted Average) value was $82.6 million (recorded in 2024), while the average stood at $82.1 million.
  • Per our database at Business Quant, Idexx Laboratories' Shares Outstanding (Weighted Average) increased by 0.41% in 2021 and then dropped by 2.80% in 2025.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Shares Outstanding (Weighted Average) stood at $84.8 million in 2021, then declined by 2.33% to $82.8 million in 2022, then grew by 0.33% to $83.1 million in 2023, then decreased by 1.45% to $81.9 million in 2024, then declined by 2.80% to $80.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $80.0 million in Q3 2025, compared to $80.4 million in Q2 2025 and $81.3 million in Q1 2025.